Related Experiment Video
Updated: Jun 1, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Prevention of cardioembolic stroke
William David Freeman1, Maria I Aguilar
1Department of Neurology, Mayo Clinic, Jacksonville, FL, USA. freeman.william1@mayo.edu
Atrial fibrillation (AF) is a common cause of cardioembolic stroke. Anticoagulation, particularly newer agents like dabigatran, is superior to antiplatelets for preventing AF-related ischemic stroke and reducing bleeding risk.
Area of Science:
- Cardiology
- Neurology
- Vascular Medicine
Background:
- Cardiac causes of ischemic stroke, particularly from large intracranial artery occlusion, result in severe neurological deficits.
- Atrial fibrillation (AF) is the most frequent cause of cardioembolic stroke, with incidence rising with age.
- Anticoagulation therapy is more effective than antiplatelet therapy for preventing ischemic strokes in patients with AF.
Purpose of the Study:
- To compare the efficacy and safety of warfarin versus dabigatran, a direct thrombin inhibitor, in preventing ischemic stroke.
- To explore emerging diagnostic tools and treatment strategies for cardioembolic stroke prevention.
Main Methods:
- Review of AF stroke trials comparing anticoagulation and antiplatelet therapies.
- Comparison of warfarin with dabigatran, assessing ischemic stroke reduction and intracranial bleeding risk.
- Discussion of other cardioembolic sources and diagnostic modalities like cardiac MRI.
Main Results:
- Dabigatran demonstrated at least equal effectiveness to warfarin in reducing ischemic stroke.
- Dabigatran was associated with a lower risk of intracranial bleeding compared to warfarin.
- Warfarin has limitations including a narrow therapeutic index, need for monitoring, drug interactions, and higher bleeding risk.
Conclusions:
- Anticoagulation is superior to antiplatelet therapy for cardioembolic stroke prevention in AF.
- Direct thrombin inhibitors like dabigatran offer a promising alternative to warfarin.
- Early detection and management of AF, alongside addressing underlying mechanisms, are crucial for preventing cardioembolic stroke.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Coronary Artery Disease IV: Preventive Measures
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Ischemic Stroke l: Introduction
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
